Form SC 13G VERSAR INC Filed by: Frigate Ventures LP
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Ebola-Related Stock Versar (VSR) Swings to Q1 Loss
November 5, 2014 9:03 AM ESTVersar (NYSE: VSR) reported Q1 EPS of ($0.01), versus $0.07 reported last year. Revenue for the quarter came in at $29.6 million, versus $29.1 million reported last year.
Increased Funded Backlog
As of September 26, 2014, Versar recorded funded backlog of approximately $223 million, an increase of 96% compared to $114 million of funded backlog at the end of fiscal year 2014. Additionally, subsequent to the quarter end, but prior to the federal government's fiscal year end, Versar was... More
